AR
COV

Advisory Research’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Advisory Research’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-287,017
Closed -$25.9M – 351
2014
Q2 		$25.9M Sell
287,017
-11,386
-4% -$852K 0.24% 97
2014
Q1 		$22M Buy
+298,403
New +$20.8M 0.23% 102
2013
Q3 		– Sell
-6,832
Closed -$381K – 326
2013
Q2 		$381K Buy
+6,832
New +$395K ﹤0.01% 272

Other funds holding COV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Advisory Research's COV Position: Q3 2014 in Review

Advisory Research sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q3 2014, closing a stake of 287,017 shares — an estimated $25.9M sold.

Advisory Research first reported a position in COV in Q2 2013 and held it in 3 quarters. The position peaked at $25.9M in Q2 2014. 720 funds tracked by Wall St. Rank hold COV as of Q3 2014.

  • Advisory Research reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q3 2014 after selling out during the quarter.
  • Advisory Research sold 287,017 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q3 2014, an estimated $25.9M.
  • Advisory Research first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 3 quarters.
  • Advisory Research's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $25.9M in Q2 2014.
  • 720 funds tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q3 2014.

Based on Advisory Research's 13F filing for Q3 2014, filed 6 Nov 2014.